Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Patients need life-saving medicines made from plasma. You can donate plasma after receiving a vaccination against COVID-19.
Advocate Kyle Smith remembers missing out on fun because he was in the hospital, but says he’s grateful for the kindness of h…
Different than an IV, this method delivers medicine below the skin and can be self-administered by some patients.
CSL Behring’s largest R&D and manufacturing site is in this university town, where game-changing science is happening.
Broadening access to clinical trials is better for science and patients.
Ahead of all employees soon returning to working on-sites, CSL CEO Paul Perreault puts in time at the company’s Pennsylvania …
Learn more about this commonly misdiagnosed disease associated with weakness, numbness and tingling in the arms and legs.
“It is personal. My headquarters are in Melbourne, I want to get back,” Perreault tells the Australian Financial Review’s BOS…
Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for Seqirus, discusses vaccine safety on new episode of Wo…
Americas
Asia Pacific
Middle East
Europe
